| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2007-08-24 | 2007-06-30 | N-Q | Pozen Inc | POZN | US | Medical-Drugs | 76,200 | New Holding | 76,200 | 100 % | $742,188 | $533,400 | $-208,788 | -28.13 % | $-208,788 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Pozen Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 841,300 | New Holding | 841,300 | 100 % | $35,915,097 | $20,031,353 | $-15,883,744 | -44.22 % | $-15,883,744 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Myriad Genetics Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Xoma Ltd | XOMA | US | Medical-Biomedical/Gene | 302,900 | Added More | 7,500 | 2.53 % | $696,670 | $221,117 | $-475,553 | -68.26 % | $-11,775 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Xoma Ltd |
| 2007-08-24 | 2007-06-30 | N-Q | Manor Care Inc | HCR | US | Medical-Nursing Homes | 614,500 | No Change | 0 | 0 % | $39,192,810 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Manor Care Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Cyberonics Inc | CYBX | US | Medical Products | 545,800 | Added More | 13,500 | 2.53 % | $9,163,982 | $10,255,582 | $1,091,600 | 11.91 % | $27,000 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cyberonics Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Johnson And Johnson | JNJ | US | Medical Products | 484,800 | Sold Some | -315,100 | -39.39 % | $29,999,424 | $30,392,112 | $392,688 | 1.30 % | $-255,231 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Johnson And Johnson |
| 2007-08-24 | 2007-06-30 | N-Q | Senorx Inc | SENO | US | Medical Instruments | 258,500 | Added More | 6,400 | 2.53 % | $2,248,950 | $1,227,875 | $-1,021,075 | -45.40 % | $-25,280 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Senorx Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Stryker Corp | SYK | US | Medical Products | 703,400 | Sold Some | -188,500 | -21.13 % | $47,261,446 | $34,832,368 | $-12,429,078 | -26.29 % | $3,330,795 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Stryker Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Merck And Co Incnj | MRK | US | Medical-Drugs | 1,333,300 | Added More | 32,900 | 2.52 % | $67,758,306 | $48,558,786 | $-19,199,520 | -28.33 % | $-473,760 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Merck And Co Incnj |
| 2007-08-24 | 2007-06-30 | N-Q | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 118,500 | Added More | 2,900 | 2.50 % | $1,234,770 | $1,113,900 | $-120,870 | -9.78 % | $-2,958 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Seattle Genetics Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Biomet Inc | BMET | US | Medical Products | 445,800 | No Change | 0 | 0 % | $20,368,602 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Biomet Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Phase Forward Inc | PFWD | US | Medical Information Sys | 124,300 | New Holding | 124,300 | 100 % | $2,264,746 | $2,048,464 | $-216,282 | -9.54 % | $-216,282 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Phase Forward Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Kyphon Inc | KYPH | US | Medical Instruments | 130,100 | New Holding | 130,100 | 100 % | $8,693,282 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Kyphon Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Owens And Minor Inc | OMI | US | Distribution/Wholesale | 229,500 | New Holding | 229,500 | 100 % | $9,154,755 | $9,074,430 | $-80,325 | -0.87 % | $-80,325 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Owens And Minor Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Millipore Corp | MIL | US | Medical-Biomedical/Gene | 174,900 | New Holding | 174,900 | 100 % | $12,435,390 | $11,945,670 | $-489,720 | -3.93 % | $-489,720 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Millipore Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 596,400 | Added More | 14,700 | 2.52 % | $37,507,596 | $27,905,556 | $-9,602,040 | -25.60 % | $-236,670 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Biogen Idec Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Cephalon Inc | CEPH | US | Medical-Drugs | 75,500 | New Holding | 75,500 | 100 % | $5,570,390 | $4,111,730 | $-1,458,660 | -26.18 % | $-1,458,660 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cephalon Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Thoratec Corp | THOR | US | Medical Instruments | 644,300 | Added More | 166,000 | 34.70 % | $13,459,427 | $19,283,899 | $5,824,472 | 43.27 % | $1,500,640 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Thoratec Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Becton Dickinson And Co | BDX | US | Medical Products | 619,000 | Added More | 112,400 | 22.18 % | $47,966,310 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Becton Dickinson And Co |
| 2007-08-24 | 2007-06-30 | N-Q | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 310,600 | Added More | 7,700 | 2.54 % | $15,408,866 | $9,032,248 | $-6,376,618 | -41.38 % | $-158,081 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Unitedhealth Group Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Arqule Inc | ARQL | US | Medical-Biomedical/Gene | 212,100 | New Holding | 212,100 | 100 % | $1,575,903 | $740,229 | $-835,674 | -53.02 % | $-835,674 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Arqule Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Aetna Inc | AET | US | Medical-Hmo | 593,200 | Added More | 14,600 | 2.52 % | $29,713,388 | $17,487,536 | $-12,225,852 | -41.14 % | $-300,906 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Aetna Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Alcon Inc | ACL | CH | Optical Supplies | 186,000 | Added More | 27,000 | 16.98 % | $25,247,640 | $27,425,700 | $2,178,060 | 8.62 % | $316,170 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Alcon Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Abbott Laboratories | ABT | US | Medical-Drugs | 683,600 | Added More | 16,900 | 2.53 % | $35,909,508 | $36,319,668 | $410,160 | 1.14 % | $10,140 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Abbott Laboratories |
| 2007-08-24 | 2007-06-30 | N-Q | Kosan Biosciences Inc | KOSN | US | Medical-Biomedical/Gene | 0 | Sold All | -820,787 | -100 % | - | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Kosan Biosciences Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Green Wind Energy As | HOLD.CO | DK | Unknown | 0 | Sold All | -500,900 | -100 % | - | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Green Wind Energy As |
| 2007-08-24 | 2007-06-30 | N-Q | Waters Corp | WAT | US | Instruments-Scientific | 98,067 | Added More | 2,400 | 2.50 % | $6,170,376 | $5,788,895 | $-381,481 | -6.18 % | $-9,336 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Waters Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Imclone Systems Inc | IMCL | US | Therapeutics | 315,200 | New Holding | 315,200 | 100 % | $10,139,984 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Imclone Systems Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Zimmer Holdings Inc | ZMH | US | Medical Products | 302,500 | Added More | 7,500 | 2.54 % | $23,613,150 | $17,532,900 | $-6,080,250 | -25.74 % | $-150,750 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Zimmer Holdings Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Cvscaremark Corp | CVS | US | Retail-Drug Store | 322,500 | New Holding | 322,500 | 100 % | $11,868,000 | $10,284,525 | $-1,583,475 | -13.34 % | $-1,583,475 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cvscaremark Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 601,381 | Added More | 14,800 | 2.52 % | $11,787,068 | $6,446,804 | $-5,340,263 | -45.30 % | $-131,424 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Intermune Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Medtronic Inc | MDT | US | Medical Instruments | 747,600 | Added More | 18,400 | 2.52 % | $40,325,544 | $30,135,756 | $-10,189,788 | -25.26 % | $-250,792 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Medtronic Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Varian Inc | VARI | US | Instruments-Scientific | 219,900 | Added More | 5,400 | 2.51 % | $13,374,318 | $11,269,875 | $-2,104,443 | -15.73 % | $-51,678 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Varian Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Wyeth | WYE | US | Medical-Drugs | 773,300 | Added More | 70,600 | 10.04 % | $36,321,901 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Wyeth |
| 2007-08-24 | 2007-06-30 | N-Q | St Jude Medical Inc | STJ | US | Medical Instruments | 146,100 | New Holding | 146,100 | 100 % | $6,444,471 | $5,114,961 | $-1,329,510 | -20.63 % | $-1,329,510 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of St Jude Medical Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Covance Inc | CVD | US | Medical Labs And Testing Srv | 158,800 | New Holding | 158,800 | 100 % | $11,643,216 | $8,510,092 | $-3,133,124 | -26.90 % | $-3,133,124 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Covance Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Schering-Plough Corp | SGP | US | Medical-Drugs | 1,316,600 | Added More | 32,500 | 2.53 % | $40,564,446 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Schering-Plough Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 236,800 | Sold Some | -181,500 | -43.38 % | $17,407,168 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Genentech Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Pfizer Inc | PFE | US | Medical-Drugs | 493,459 | Added More | 12,200 | 2.53 % | $12,208,176 | $9,143,795 | $-3,064,380 | -25.10 % | $-75,762 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Pfizer Inc |
| 2007-08-24 | 2007-06-30 | N-Q | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 0 | Sold All | -304,200 | -100 % | - | - | - | -59.69 % | $1,770,444 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cardiome Pharma Corp |
| 2007-08-24 | 2007-06-30 | N-Q | Roche Holding Ag | RHHBY.OB | CH | Medical-Drugs | 341,900 | Added More | 8,400 | 2.51 % | $30,018,820 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Roche Holding Ag |
| 2007-08-24 | 2007-06-30 | N-Q | Gilead Sciences Inc | GILD | US | Therapeutics | 1,358,400 | Added More | 679,200 | 100.00 % | $50,654,736 | $63,858,384 | $13,203,648 | 26.06 % | $6,601,824 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Gilead Sciences Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Pharmion Corp | PHRM | US | Medical-Drugs | 0 | Sold All | -427,600 | -100 % | - | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Pharmion Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Kosan Biosciences Inc | KOSN | US | Medical-Biomedical/Gene | 820,787 | New Holding | 820,787 | 100 % | $4,924,722 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Kosan Biosciences Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Cyberonics Inc | CYBX | US | Medical Products | 532,300 | Added More | 103,000 | 23.99 % | $9,687,860 | $10,001,917 | $314,057 | 3.24 % | $60,770 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cyberonics Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 304,200 | Added More | 58,900 | 24.01 % | $3,084,588 | $1,195,506 | $-1,889,082 | -61.24 % | $-365,769 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cardiome Pharma Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Affymax Inc | AFFY | US | Medical-Biomedical/Gene | 0 | Sold All | -74,700 | -100 % | - | - | - | -31.62 % | $713,385 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Affymax Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Stryker Corp | SYK | US | Medical Products | 891,900 | Added More | 197,500 | 28.44 % | $59,382,702 | $44,166,888 | $-15,215,814 | -25.62 % | $-3,369,350 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Stryker Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Mentor Corp | MNT | US | Medical Products | 0 | Sold All | -31,266 | -100 % | - | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Mentor Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 586,581 | Added More | 236,000 | 67.31 % | $15,632,384 | $6,288,148 | $-9,344,235 | -59.77 % | $-3,759,480 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Intermune Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Davita Inc | DVA | US | Dialysis Centers | 0 | Sold All | -299,100 | -100 % | - | - | - | 9.21 % | $-1,513,446 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Davita Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Quest Diagnostics Incde | DGX | US | Medical Labs And Testing Srv | 0 | Sold All | -93,600 | -100 % | - | - | - | 20.84 % | $-949,104 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Quest Diagnostics Incde |
| 2007-06-06 | 2007-03-31 | N-CSRS | Xoma Ltd | XOMA | US | Medical-Biomedical/Gene | 295,400 | New Holding | 295,400 | 100 % | $1,001,406 | $215,642 | $-785,764 | -78.46 % | $-785,764 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Xoma Ltd |
| 2007-06-06 | 2007-03-31 | N-CSRS | Senorx Inc | SENO | US | Medical Instruments | 252,100 | New Holding | 252,100 | 100 % | $2,647,050 | $1,197,475 | $-1,449,575 | -54.76 % | $-1,449,575 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Senorx Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 115,600 | New Holding | 115,600 | 100 % | $1,218,424 | $1,086,640 | $-131,784 | -10.81 % | $-131,784 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Seattle Genetics Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Becton Dickinson And Co | BDX | US | Medical Products | 506,600 | Added More | 190,600 | 60.31 % | $37,878,482 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Becton Dickinson And Co |
| 2007-06-06 | 2007-03-31 | N-CSRS | Alcon Inc | ACL | CH | Optical Supplies | 159,000 | Added More | 35,200 | 28.43 % | $21,701,910 | $23,444,550 | $1,742,640 | 8.02 % | $385,792 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Alcon Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Green Wind Energy As | HOLD.CO | DK | Unknown | 500,900 | New Holding | 500,900 | 100 % | $475,855 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Green Wind Energy As |
| 2007-06-06 | 2007-03-31 | N-CSRS | Varian Inc | VARI | US | Instruments-Scientific | 214,500 | New Holding | 214,500 | 100 % | $12,106,380 | $10,993,125 | $-1,113,255 | -9.19 % | $-1,113,255 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Varian Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 418,300 | Added More | 92,500 | 28.39 % | $31,748,970 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Genentech Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Allergan Incunited States | AGN | US | Medical-Drugs | 0 | Sold All | -214,000 | -100 % | - | - | - | -52.03 % | $13,606,120 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Allergan Incunited States |
| 2007-06-06 | 2007-03-31 | N-CSRS | Gilead Sciences Inc | GILD | US | Therapeutics | 679,200 | Added More | 150,400 | 28.44 % | $55,293,672 | $31,929,192 | $-23,364,480 | -42.25 % | $-5,173,760 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Gilead Sciences Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 0 | Sold All | -229,600 | -100 % | - | - | - | -36.84 % | $3,189,144 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Myriad Genetics Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Manor Care Inc | HCR | US | Medical-Nursing Homes | 614,500 | Added More | 135,900 | 28.39 % | - | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Manor Care Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Johnson And Johnson | JNJ | US | Medical Products | 799,900 | Added More | 177,100 | 28.43 % | $50,313,710 | $50,145,731 | $-167,979 | -0.33 % | $-37,191 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Johnson And Johnson |
| 2007-06-06 | 2007-03-31 | N-CSRS | Health Net Inc | HNT | US | Medical-Hmo | 0 | Sold All | -202,300 | -100 % | - | - | - | -63.38 % | $7,250,432 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Health Net Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Merck And Co Incnj | MRK | US | Medical-Drugs | 1,300,400 | Added More | 288,100 | 28.45 % | $66,008,304 | $47,360,568 | $-18,647,736 | -28.25 % | $-4,131,354 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Merck And Co Incnj |
| 2007-06-06 | 2007-03-31 | N-CSRS | Biomet Inc | BMET | US | Medical Products | 445,800 | Added More | 136,100 | 43.94 % | $19,704,360 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Biomet Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 581,700 | Added More | 104,900 | 22.00 % | $30,201,864 | $27,217,743 | $-2,984,121 | -9.88 % | $-538,137 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Biogen Idec Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Thoratec Corp | THOR | US | Medical Instruments | 478,300 | New Holding | 478,300 | 100 % | $9,192,926 | $14,315,519 | $5,122,593 | 55.72 % | $5,122,593 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Thoratec Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 302,900 | Added More | 67,100 | 28.45 % | $16,347,513 | $8,808,332 | $-7,539,181 | -46.11 % | $-1,670,119 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Unitedhealth Group Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Aetna Inc | AET | US | Medical-Hmo | 578,600 | Added More | 128,100 | 28.43 % | $29,693,752 | $17,057,128 | $-12,636,624 | -42.55 % | $-2,797,704 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Aetna Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Abbott Laboratories | ABT | US | Medical-Drugs | 666,700 | Added More | 299,700 | 81.66 % | $36,495,158 | $35,421,771 | $-1,073,387 | -2.94 % | $-482,517 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Abbott Laboratories |
| 2007-06-06 | 2007-03-31 | N-CSRS | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 0 | Sold All | -590,023 | -100 % | - | - | - | -1.81 % | $613,624 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Amgen Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Waters Corp | WAT | US | Instruments-Scientific | 95,667 | Sold Some | -496,933 | -83.85 % | $5,835,687 | $5,647,223 | $-188,464 | -3.22 % | $978,958 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Waters Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Zimmer Holdings Inc | ZMH | US | Medical Products | 295,000 | Added More | 65,300 | 28.42 % | $25,600,100 | $17,098,200 | $-8,501,900 | -33.21 % | $-1,881,946 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Zimmer Holdings Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Cerner Corp | CERN | US | Medical Information Sys | 0 | Sold All | -51,300 | -100 % | - | - | - | 40.17 % | $-1,141,938 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Cerner Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Medtronic Inc | MDT | US | Medical Instruments | 729,200 | Added More | 161,500 | 28.44 % | $38,319,460 | $29,394,052 | $-8,925,408 | -23.29 % | $-1,976,760 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Medtronic Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Wyeth | WYE | US | Medical-Drugs | 702,700 | Added More | 155,500 | 28.41 % | $40,412,277 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Wyeth |
| 2007-06-06 | 2007-03-31 | N-CSRS | Schering-Plough Corp | SGP | US | Medical-Drugs | 1,284,100 | Added More | 284,100 | 28.41 % | $40,911,426 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Schering-Plough Corp |
| 2007-06-06 | 2007-03-31 | N-CSRS | Pfizer Inc | PFE | US | Medical-Drugs | 481,259 | Sold Some | -394,400 | -45.04 % | $12,892,929 | $8,917,729 | $-3,975,199 | -30.83 % | $3,257,744 | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Pfizer Inc |
| 2007-06-06 | 2007-03-31 | N-CSRS | Roche Holding Ag | RHHBY.OB | CH | Medical-Drugs | 333,500 | Added More | 232,800 | 231.18 % | $30,231,775 | - | - | - % | | | | | | | News Article | History of Blackrock Funds - Blackrock Health Sciences Opportunities Portfolio Ownership Of Roche Holding Ag |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |